Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. It is specifically...
69 KB (6,103 words) - 11:49, 17 November 2024
Trastuzumab deruxtecan, sold under the brand name Enhertu, is an antibody-drug conjugate consisting of the humanized monoclonal antibody trastuzumab (Herceptin)...
25 KB (2,086 words) - 02:24, 16 July 2024
Trastuzumab emtansine, sold under the brand name Kadcyla, is an antibody-drug conjugate consisting of the humanized monoclonal antibody trastuzumab (Herceptin)...
29 KB (2,696 words) - 14:16, 27 July 2024
Pertuzumab/trastuzumab/hyaluronidase, sold under the brand name Phesgo, is a fixed-dose combination medication to treat adults with HER2-positive breast...
12 KB (966 words) - 04:46, 15 July 2024
Cancer immunotherapy (section Trastuzumab)
system. Examples of such antibodies include rituximab (targeting CD-20), trastuzumab (targeting HER-2), and cetuximab (targeting EGFR). Passive antibody therapies...
92 KB (12,517 words) - 05:38, 1 October 2024
Trastuzumab/hyaluronidase, sold under the brand name Herceptin SC among others, is a fixed-dose combination medication for the treatment of HER2-overexpressing...
11 KB (703 words) - 18:13, 27 March 2024
antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-expressed. One year of trastuzumab therapy is...
43 KB (4,651 words) - 13:41, 27 July 2024
brand name Perjeta, is a monoclonal antibody used in combination with trastuzumab and docetaxel for the treatment of metastatic HER2-positive breast cancer;...
24 KB (2,276 words) - 04:42, 1 October 2024
2021. Tucatinib is a kinase inhibitor indicated in combination with trastuzumab and capecitabine for the treatment of adults with advanced unresectable...
21 KB (1,685 words) - 05:17, 16 July 2024
authorization from the European Medicines Agency in October 2012. Trastuzumab emtansine (ado-trastuzumab emtansine or T-DM1, trade name: Kadcyla, marketed by Genentech...
41 KB (4,305 words) - 11:56, 24 August 2024
example, a targeted anticancer agent – trastuzumab emtansine (antibody-drug conjugate containing an antibody trastuzumab chemically linked to a highly potent...
2 KB (97 words) - 22:42, 6 February 2024
Isatuximab L01FD01 Trastuzumab L01FD02 Pertuzumab L01FD03 Trastuzumab emtansine L01FD04 Trastuzumab deruxtecan L01FD05 Trastuzumab duocarmazine L01FD06...
12 KB (877 words) - 15:36, 25 January 2024
of camptothecin with antineoplastic activity. A derivative is used in Trastuzumab deruxtecan. Abou-Alfa, GK; Letourneau, R; Harker, G; Modiano, M; Hurwitz...
3 KB (98 words) - 05:18, 1 January 2024
aspart, insulin glargine, pegfilgrastim, rituximab, teriparatide, and trastuzumab. A research article about "Maximizing the benefits of using biosimilars...
97 KB (6,512 words) - 06:28, 8 October 2024
Kadcyla (ado-trastuzumab emtansine): The first Genentech antibody-drug conjugate (ADC) to receive FDA approval. It consists of trastuzumab (Herceptin)...
32 KB (2,865 words) - 04:21, 4 October 2024
Uterine serous carcinoma (section Trastuzumab)
antibody trastuzumab (Herceptin) is currently being tested as a therapy for this subset of uterine serous carcinomas. The antibody trastuzumab (Herceptin)...
10 KB (1,197 words) - 17:13, 13 June 2024
create an antibody-drug conjugate (ADC). ADCs with this design include trastuzumab emtansine, lorvotuzumab mertansine, and cantuzumab mertansine. Some are...
6 KB (471 words) - 09:43, 12 February 2024
HER2-targeted antibody trastuzumab to chemotherapy reduces the chance of cancer recurrence and death by at least a third. Trastuzumab is given weekly or every...
134 KB (15,172 words) - 09:52, 13 November 2024
antibody treatments, notably for lymphoma (Rituximab) and breast cancer (Trastuzumab). Vaccines and other immunotherapies are the subject of intensive research...
24 KB (2,589 words) - 20:46, 24 September 2024
(Rituxan Hycela), trastuzumab/hyaluronidase-oysk (Herceptin Hylecta), daratumumab/hyaluronidase-fihj (Darzalex Faspro), and pertuzumab/trastuzumab/hyaluronidase–zzxf...
34 KB (3,092 words) - 05:38, 14 September 2024
other cardiotoxic chemotherapy drugs, such as trastuzumab. There is an FDA black box warning that trastuzumab cannot be used in concurrent combination with...
49 KB (4,504 words) - 07:10, 21 November 2024
Cancer Institute. He is best known for his research on treatments with trastuzumab in HER2-positive breast cancers. Pivot was born on April 20, 1967, in...
11 KB (1,127 words) - 17:13, 3 December 2023
NK cell effector functions during NK cell anti-tumor immunotherapy. Trastuzumab is a monoclonal anti-HER2 antibody that is used as a treatment of the...
75 KB (9,227 words) - 23:32, 16 October 2024
(INN) trapencaine (INN) trapidil (INN) Trasicor Trastucip trastuzumab emtansine (INN) trastuzumab (INN) Trasylol Travamulsion Travase Travasol Travatan travoprost...
12 KB (563 words) - 00:00, 1 October 2024
proteins to activate the NK cell. The effects against solid tumors of trastuzumab and rituximab monoclonal antibodies have been shown in experiments with...
13 KB (1,661 words) - 22:18, 9 December 2023
monoclonal antibody (mAb) approved by the EMA. Herzuma is a biosimilar trastuzumab approved by the MFDS for treatment of early and advanced (metastatic)...
12 KB (809 words) - 09:31, 17 November 2024
lymphocytic leukaemia. Hemlibra (emicizumab), for haemophilia A. Herceptin (trastuzumab), for HER-2 positive breast cancer. Hivid (zalcitabine), for HIV-1 infection...
57 KB (5,195 words) - 10:21, 4 November 2024
TCH is a chemotherapy regimen consisting of Taxotere (docetaxel), carboplatin and Herceptin (trastuzumab), which is used to treat breast cancer. v t e...
623 bytes (23 words) - 14:38, 23 October 2018
likely to respond to treatment. Because the breast cancer medication trastuzumab is known to target protein HER2, for example, tumors can be screened...
17 KB (1,857 words) - 06:00, 19 August 2024
Sankyo.” This list is not comprehensive. Oncology Enhertu (trastuzumab deruxtecan, fam-trastuzumab deruxtecan-nxki in the United States only) Ezharmia (valemetostat)...
28 KB (2,326 words) - 02:38, 5 September 2024